https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/accounts-payable https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/accrued-liabilities-current https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/accrued-salaries-current https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/accumulated-depreciation https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/additional-paid-in-capital https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/basic-shares https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/capital-expenditures https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/cash-and-equivalents https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/cash-flow-breakdown https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/common-stock-value https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/contract-liability https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/contract-with-customer-liability-noncurrent https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/current-assets https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/current-liabilities https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/debt-issuance-costs-incurred-during-noncash-or-partial-noncash-transaction https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/debt-repaid https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/deferred-income-tax-liabilities https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/deferred-offering-costs https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/deferred-revenue https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/deferred-revenue-noncurrent https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/deferred-tax-assets-deferred-income https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/deferred-tax-assets-property-plant-and-equipment https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/deferred-tax-liabilities-property-plant-and-equipment https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/defined-contribution-plan-cost-recognized https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/defined-contribution-plan-employer-discretionary-contribution-amount https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/defined-contribution-plan-employer-matching-contribution-percent https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/defined-contribution-plan-employer-matching-contribution-percent-of-match https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/depreciation https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/diluted-shares https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/effective-tax-rate https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/eps https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/eps-basic https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/financing-cash-flow https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/foreign-currency-transaction-gain-loss-before-tax https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/foreign-pretax-income https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/form-d-other https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/gain-loss-on-disposition-of-assets https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/general-and-administrative-expense https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/impairment-of-long-lived-assets-held-for-use https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/income-tax https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/increase-decrease-in-contract-with-customer-liability https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/insider-transactions-preferred https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/insurance-settlements-receivable-current https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/interest-income-expense-net https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/interest-income-expense-nonoperating-net https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/interest-paid https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/investing-cash-flow https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/investment-income-interest https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/issuance-of-stock-and-warrants-for-services-or-claims https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/lease-and-rental-expense https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/lease-cost https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/litigation-reserve-current https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/net-cash-from https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/net-change-in-cash https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/net-income https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/number-of-operating-segments https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/operating-cash-flow https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/operating-expenses https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/operating-income https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/operating-lease-assets https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/operating-lease-cost https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/operating-lease-expense https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/operating-lease-liability https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/operating-lease-liability-current https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/operating-lease-payments https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/operating-lease-payments-due https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/operating-loss-carryforwards https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/other-current-assets https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/other-income https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/other-noncurrent-assets https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/paid-in-capital-increase-in-carrying-amount-of-redeemable-preferred-stock https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/preferred-shares-facts https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/prepaid-expense-current https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/prepaid-insurance https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/pretax-income https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/pretax-income-domestic https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/proceeds-from-issuance-of-convertible-preferred-stock https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/proceeds-from-issuance-of-redeemable-convertible-preferred-stock https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/profit-loss https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/property-plant-equipment https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/public-float https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/research-and-development https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/retained-earnings https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/revenue https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/revenue-from-contract-with-customer-excluding-assessed-tax https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/sales-revenue-net https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/shareholders-equity https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/shares-authorized https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/shares-issued https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/stock-award-number-of-shares-authorized https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/stock-award-number-of-shares-available-for-grant https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/stock-based-compensation https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/stock-issued-shares-issued-shares-new-issues https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/stock-split-ratio https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/tax-rate-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/tax-rate-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/tax-rate-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/tax-rate-reconciliation-nondeductible-expense-other https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/tax-rate-reconciliation-nondeductible-expense-research-and-development https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/tax-rate-reconciliation-prior-year-income-taxes https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/tax-rate-reconciliation-tax-credits-research https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/temporary-equity-accretion-of-dividends https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/temporary-equity-accretion-to-redemption-value https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/temporary-equity-carrying-amount-attributable-to-parent https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/temporary-equity-liquidation-preference https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/temporary-equity-liquidation-preference-per-share https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/temporary-equity-par-or-stated-value-per-share https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/temporary-equity-redemption-price-per-share https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/temporary-equity-shares-authorized https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/temporary-equity-shares-issued https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/temporary-equity-shares-outstanding https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/total-assets https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/total-liabilities https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/utb-income-tax-penalties-and-interest-accrued https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/variable-lease-cost https://stock.noler.com/us/stock/zynerba-pharmaceuticals-inc/weighted-average-number-of-share-outstanding-basic-and-diluted